Skip to content

Better Living With Non-memory-led Dementia

Better Living With Non-memory-led Dementia: Feasibility Study on the Effects of a Blended Online Training Course for Carers of People With Atypical AD and FTD.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05525377
Enrollment
31
Registered
2022-09-01
Start date
2022-06-21
Completion date
2023-02-09
Last updated
2023-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimer Disease, Frontotemporal Dementia, Primary Progressive Aphasia

Keywords

Posterior Cortical Atrophy

Brief summary

This is a feasibility study on the effects of an online-based training and education programme for carers of people with posterior cortical atrophy (PCA), primary progressive aphasia (PPA) and behavioural-variant frontotemporal dementia (bvFTD).

Detailed description

The purpose of this study is: To evaluate the feasibility of an online training course for carers of people with PCA, PPA, and bvFTD. Feasibility measures will focus on the recruitment process and measurement tools. To determine the acceptability of an online training course for carers of people with PCA, PPA and bvFTD. The study will involve 6 online modules over the course of 7 weeks. All sessions will take place over the internet, using an online platform. A research team member (facilitator) will be available to assist participants over the course completion.

Interventions

BEHAVIORALBetter living with non-memory led dementia course

Caregivers online training and educational phenotype-specific programme on how to support people with non-memory-led dementia.

Sponsors

University College, London
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

1. . Adults (18+) who self-identify as an unpaid carer (partners, children, friends, etc.) of someone with PPA, PCA or bvFTD who is not living in a full-time care facility. 2. . The care recipient has to have a confirmed diagnosis of dementia (through self-report of the carer, to reflect the 'real world' application of the intervention).

Exclusion criteria

1. . Those unable to comprehend written English 2. . Those with no access to the internet

Design outcomes

Primary

MeasureTime frameDescription
Study feasibilitySince June 2022 to January 2023 (8 months)Feasibility of recruitment process and measurement tools (e.g., number of people agreeing to be sent information about the study, time taken to fill in questionnaires).
AcceptabilitySince June 2022 to January 2023 (8 months)Prospective and retrospective acceptability (e.g., reasons for not taking part, task completion rate after every module)

Secondary

MeasureTime frameDescription
Patient Health Questionnaire (PHQ-9)Change from baseline to 8 weeks and 3 monthsAssesses depression severity (ranging from 0 (minimun) to 27 (maximun) scores. Higher scores indicate higher depression.
De Jong Gierveld Loneliness ScaleChange from baseline to 8 weeks and 3 monthsMeasure variations in total loneliness score ranging from 0 (minimun) to 11 (maximun) scores. 0 meaning not lonely and 100 very severe lonely score.
Lubben Social Network ScaleChange from baseline to 8 weeks and 3 monthsBrief instrument designed to gauge social isolation in older adults by measuring perceived social support received by family and friends. Ranging from 0 (minimun) to 60 (maximun) scores. Higher scores represent higher social network.
Pearling Mastery ScaleChange from baseline to 8 weeks and 3 monthsMeasures the extent to which an individual regards their life chances as being under their personal control. Ranging from 7 (minimun) to 28 (maximun) scores. Higher scores indicate greater levels of mastery.
WHO 5 Wellbeing IndexChange from baseline to 8 weeks and 3 monthsShort self-reported measure of current mental wellbeing (ranging from 0 (minimun) to 25 (maximun) scores). 0 representing the worst imaginable well-being and 100 representing the best imaginable well-being.
Dementia Management Strategies ScaleChange from baseline to 8 weeks and 3 monthsInstrument to appraise 3 care styles of caregivers: 1) Active management, 2) Criticism and 3) Encouragement. Ranging from 34 (minimun) to 170 (maximun). Higher scores mean a greater presence of behaviours associated to the the corresponding caregiver style.
The quality of carer-partner relationship scaleChange from baseline to 8 weeks and 3 monthsScale that measures closeness in a relationship. Ranging from 14 (minimun) to 70 (maximun). Higher scores reflect higher quality of carer-partner relationship.
Questions about perceived burden and ethicalityAt 8 weeks post-randomisation and 3 month follow upTailored questions administered in a purposed-built interview. They
Health economics questionsAt 8 weeks post-randomisation and 3 month follow upTailored questions administered in a purposed-built interview.
Caregiver self-efficacy scaleChange from baseline to 8 weeks and 3 monthsMeasures caregivers' beliefs about their ability to carry out behaviors such as obtaining respite, responding to disruptive patient behaviors, etc. Ranging from 0 (minimun) to 100 (maximun) scores. Higher scores reflect higher confidence.
Generalized Anxiety Disorder scale (GAD-7)Change from baseline to 8 weeks and 3 monthsGeneralized Anxiety Disorder scale (ranging from 0 (minimun) to 21 (maximun) scores). Higher scores indicates higher anxiety.

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 8, 2026